Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Use of Bioadhesive Polymers in Nanoparticle Formulations

Posted on By

SOP for Use of Bioadhesive Polymers in Nanoparticle Formulations

Standard Operating Procedure for Use of Bioadhesive Polymers in Nanoparticle Formulations

1) Purpose

This SOP outlines the procedure for incorporating bioadhesive polymers into nanoparticle formulations, enhancing their adhesion to biological tissues and improving the residence time of the therapeutic agent at the target site.

2) Scope

This SOP applies to personnel involved in the preparation and characterization of bioadhesive nanoparticle formulations used for drug delivery, particularly for mucosal or topical applications.

3) Responsibilities

  • Operators: Responsible for incorporating bioadhesive polymers into nanoparticle formulations as per this SOP.
  • QA: Ensures that bioadhesive formulations meet stability, adhesion, and release profile specifications.
See also  Nanoparticle Formulation : SOP for Preparation of Liposomal Nanoparticles

4) Procedure

4.1 Selection of Bioadhesive Polymers

4.1.1 Common Polymers

  • 4.1.1.1 Select bioadhesive polymers such as chitosan, polycarbophil, or alginate based on their compatibility with the nanoparticle and the intended route of administration.

4.2 Incorporation of Bioadhesive Polymers

4.2.1 Mixing Procedure

  • 4.2.1.1 Add the selected bioadhesive polymer to the nanoparticle formulation during or after the nanoparticle preparation process, ensuring thorough mixing for uniform coating or incorporation.

4.3 Testing for Adhesion and Stability

4.3.1 In Vitro Adhesion Testing

  • 4.3.1.1 Perform in vitro adhesion tests to measure the bioadhesive strength of the nanoparticles on mucosal or biological tissue models.

4.3.2 Stability Testing

  • 4.3.2.1 Conduct stability tests under various environmental conditions to ensure that the bioadhesive
nanoparticles maintain their properties during storage and use.

4.4 Storage

4.4.1 Storage Conditions

  • 4.4.1.1 Store bioadhesive nanoparticle formulations in sealed, sterile containers at 4°C to maintain stability and bioadhesion properties over time.

5) Abbreviations, if any

  • QA: Quality Assurance

6) Documents, if any

  • Bioadhesive Nanoparticle Formulation Logbook

7) References, if any

  • Guidelines for bioadhesive polymer use in nanoparticle formulations

8) SOP Version

Version 1.0

Annexure

Bioadhesive Nanoparticle Formulation Logbook Template

Date Batch Number Bioadhesive Polymer Used Concentration Adhesion Test Results Operator Initials QA Initials
DD/MM/YYYY Batch Number Polymer Name Concentration (w/v %) Pass/Fail Operator Name QA Name
           
See also  SOP for Formulating Nanoparticles for Pulmonary Delivery
Nanoparticle Formulation Tags:Nanoparticle biomedical applications SOP, Nanoparticle clinical trial SOP, Nanoparticle encapsulation SOP, Nanoparticle formulation SOP, Nanoparticle handling SOP, Nanoparticle preparation procedure, Nanoparticle production SOP, Nanoparticle quality control SOP, Nanoparticle size optimization SOP, Nanoparticle SOP, Nanoparticle stability testing SOP, Nanoparticle standard operating procedures, Nanoparticle sterilization SOP, Nanoparticle storage SOP, Nanoparticle surface modification SOP, Nanoparticle synthesis SOP, Nanoparticle toxicology SOP, SOP for nanomaterials, SOP for nanoparticle characterization, SOP for nanoparticle drug delivery, SOP for nanoparticle gene delivery, SOP for nanoparticle regulatory compliance, SOP for nanoparticle safety, SOP for nanoparticle scaling, SOP for targeted drug delivery nanoparticles

Post navigation

Previous Post: SOP for Use of Peristaltic Pumps in Formulation Processes
Next Post: SOP for Accelerated Stability Testing of Emulsion Formulations

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version